Xin Huang

Xin Huang is the Vice President of Biometrics of Vincerx. Before joining Vincerx, Dr. Huang was the Head of Biostatistics at Loxo Oncology, where she established the Biostatistics and Statistical Programming department and was responsible for the oversight of all biometrics activities. Before joining Loxo, she was Director of Biostatistics at Acerta Pharma and led the statistical support for multiple hematology and solid tumor studies. Dr. Huang began her career in oncology at Amgen, where she worked as a statistical lead for phase 2 and phase 3 studies in the trebananib program. During her career, Dr. Huang led the biometrics activities for RETEVMO (selpercatinib) approval and played a key role in CALQUENCE (acalabrutinib) MCL approval.

Dr. Huang obtained her Ph.D. in Biostatistics from the University of California, Los Angeles.